Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain

OBJECTIVE: To assess the cost-effectiveness of tofacitinib-containing treatment sequences versus sequences containing only standard biological therapies in patients with moderate-to-severe rheumatoid arthritis (RA) after the failure of conventional synthetic disease-modifying antirheumatic drugs (cs...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Rheumatol
Asıl Yazarlar: Navarro, F., Martinez-Sesmero, J. M., Balsa, A., Peral, C., Montoro, M., Valderrama, M., Gómez, S., de Andrés-Nogales, F., Casado, M. A., Oyagüez, Itziar
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497326/
https://ncbi.nlm.nih.gov/pubmed/32303858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-020-05087-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller